(Q36372525)

13 August 2017

1 reference

title

Review article: complementary and alternative therapies for inflammatory bowel disease (English)

1 reference

inflammatory bowel diseases

13 August 2017

main subject

0 references

inflammation

0 references

author name string

Langmead L

series ordinal

1

1 reference

13 August 2017

Rampton DS

series ordinal

2

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 February 2006

1 reference

Alimentary Pharmacology & Therapeutics

13 August 2017

published in

1 reference

13 August 2017

volume

23

1 reference

13 August 2017

issue

3

1 reference

13 August 2017

page(s)

341-349

1 reference

Complementary and alternative medicine in the scientific literature

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02761.X

Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02761.X

Alternative medicine--the risks of untested and unregulated remedies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02761.X

ABC of complementary medicine: herbal medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02761.X

Amount of systemic steroid medication is a strong predictor for the use of complementary and alternative medicine in patients with inflammatory bowel disease: results from a German national survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02761.X

Use of complementary therapies by patients with IBD may indicate psychosocial distress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02761.X

Knowledge, quality of life, and use of complementary and alternative medicine and therapies in inflammatory bowel disease: a comparison of Chinese and Caucasian patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02761.X

Use of alternative medicine by women with early-stage breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02761.X

Evaluation of new therapies for inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02761.X

Treatment of irritable bowel syndrome with Chinese herbal medicine: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02761.X

Randomized, double-blind, placebo-controlled trial of oral aloe vera gel for active ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02761.X

Wheat grass juice in the treatment of active distal ulcerative colitis: a randomized double-blind placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02761.X

Treatment of ulcerative colitis by feeding with germinated barley foodstuff: first report of a multicenter open control trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02761.X

Effects of gum resin of Boswellia serrata in patients with chronic colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02761.X

Therapy of active Crohn disease with Boswellia serrata extract H 15

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02761.X

The case for using 5-aminosalicyclates in Crohn's disease: pro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02761.X

Curcumin therapy in inflammatory bowel disease: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02761.X

Acupuncture and Moxibustion in the Treatment of Active Crohn’s Disease: A Randomized Controlled Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02761.X

Use of the 'nutriceutical', bovine colostrum, for the treatment of distal colitis: results from an initial study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02761.X

Review article: herbal treatment in gastrointestinal and liver disease--benefits and dangers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02761.X

Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02761.X

Psychological stress in IBD: new insights into pathogenic and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02761.X

The placebo effect in alternative medicine: can the performance of a healing ritual have clinical significance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02761.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02761.X

A tale of two therapies: psychotherapy and complementary and alternative medicine (CAM) and the human effect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02761.X

Risks of herbal medicinal products

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02761.X

Complementary and alternative medicine in gastroenterology: the good, the bad, and the ugly

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02761.X

Is acupuncture a risk factor for hepatitis? Systematic review of epidemiological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02761.X

Interaction of St John's wort with conventional drugs: systematic review of clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02761.X

International monitoring of adverse health effects associated with herbal medicines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02761.X

Herbal medicines put into context

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02761.X

Should herbal medicine-like products be licensed as medicines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02761.X

Regulating herbal medicines in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02761.X

Molecular epidemiology of a large outbreak of hepatitis B linked to autohaemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02761.X

10.1111/J.1365-2036.2006.02761.X

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference